https://doi.org/10.18502/jovr.v14i4.5447
statistics
- 1111 Abstract Views
- 570 PDF Views
- 0 HTML Views
- Cited by 3 articles
authors
-
Brahm Prakash Guliani
Brahm Prakash Guliani
Department of Ophthalmology, Vardhaman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
-
Isha Agarwal
Isha Agarwal
Department of Ophthalmology, Vardhaman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
-
Mayuresh P. Naik
Mayuresh P. Naik
Department of Ophthalmology, Hamdard Institute of Medical Sciences & Research, Hakeem Abdul Hameed Centenary Hospital, New Delhi, India
Published Date
- Oct 24, 2019
Effect of Uncomplicated Cataract Surgery on Central Macular Thickness in Diabetic and Non-diabetic Subjects
Abstract
Purpose: To assess the quantitative changes of macula in diabetic and non-diabetic eyes after uncomplicated cataract surgery.
Methods: In this prospective interventional study being performed in a tertiary healthcare hospital, a total of 660 eyes were divided into two groups. Group 1 included 330 eyes from healthy subjects and group 2 included 330 eyes from well-controlled diabetic subjects with no diabetic retinopathy planned for phacoemulsification with foldable IOL implantation by the same surgeon under similar settings. Optical Coherence Tomography (Heidelberg Spectralis SD-OCT) was used to assess preoperative and postoperative central macular thickness (CMT) at weeks 1 and 6.
Results: The mean CMT in group 1 preoperatively, at postoperative week 1, and at post-operative week 6 was 257.03 ± 20.904, 262.82 ± 17.010, and 265.15 ± 20.078 μm, respectively. The corresponding values in group 2 were 255.36 ± 17.852, 259.15 ± 16.644, and 266.09 ± 18.844 μm, respectively. There was no significant difference in the mean CMT values between the two groups on any of the three occasions when the CMT was measured (P = 0.374 and P = 0.313 at weeks 1 and 6, respectively).
Conclusion: There was no statistically significant difference in CMT between normal subjects and diabetic subjects without diabetic retinopathy preoperatively and in early postoperative period after uncomplicated phacoemulsification surgery.
Keywords:
Central Macular Thickness, Diabetic Macular Edema, Uncomplicated Phacoemulsification
References
2. Panchapakesan J, Rochtchina E, Mitchell P. Five-year change in visual acuity following cataract surgery in an older community: the Blue Mountains Eye Study. Eye 2004;18:278–282.
3. Linebarger EJ, Hardten DR, Shah GK, Lindstrom RL. Phacoemulsification and modern cataract surgery. Surv Ophthalmol 1999;44:123–147.
4. O’Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 2005;21:1131–1137. Review Erratum in: Curr Med Res Opin 2005;21:1431–1432.
5. Nelson ML, Martidis A. Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 2003;14:39– 43.
6. Nelson ML, Martidis A. Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 2003;14:39– 43.
7. Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 1966;76:646–661.
8. Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoids macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Catarct Refract Surg 1999;25:1492–1497.
9. Flach AJ. The incidence, pathogenesis and treatment of cystoids macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998;96:557–634.
10. Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg 2003;29:2378–2384.
11. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007;114:881–889.
12. AIOS guidelines to prevent intraocular infection. 2009. Available from http://www.aios.org/guidelines endoph.pdf
13. FAO; WHO. World declaration and plan of action for nutrition. In: International Conference on Nutrition. Rome: Food and Agriculture Organization of the United Nations; December 1992.
14. Dowler JG, Sehmi KS, Hykin PG, Hamilton AM. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999;106:663–668.
15. Lara SA, Cakiner ET. Diabetes and cataract surgery: preoperative risk factors and positive nursing interventions. Insight 2014;39:18–20.
16. Biro Z, Balla Z, Kovacs B. Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye 2008;22:8–12.
17. Sahin M, Cingu AK, Gozum N. Evaluation of cystoid macular edema using optical coherence tomography and fundus autofluorescence after uncomplicated phacoemulsification surgery. J Ophthalmol 2013;2013:376013.
18. Katsimpris JM. , Petropoulos IK., Zoukas G., Patokos T., Brinkmann C.K., Theoulakis P.E. Central foveal thickness before and after cataract surgery in normal and in diabetic patients without retinopathy. Klin Monbl Augenheilkd 2012; 229:331-337.
19. Akcay BI, Bozkurt TK, Güney E, Unlü C, Erdogan G, Akcali G, et al. Quantitative analysis of macular thickness following uneventful and complicated cataract surgery. Clin Ophthalmol 2012;6:1507–1511.
20. Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. Risk factors and incidence of macular edema after cataract surgery a database study of 81984 eyes. Ophthalmology 2016;123:316–323.
21. Liu J, Jones RE, Zhao J, Zhang J, Zhang F. Influence of uncomplicated phacoemulsification on central macular thickness in diabetic patients: a meta-analysis. PLoS ONE 2015;10:e0126343.
22. Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): A 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010;33:2399-405.
23. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996;80:789–793.